Salmeterol Xinafoate [salmeterol xinafoát]
topical
11
- Terms
-
salmeterol
salmeterol-xinafoát
Serevent Diskus
-
Salmeterol
Serevent
Persistent link
https://www.medvik.cz/link/D000068299
Definition
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
- DUI
- D000068299 MeSH Browser
- CUI
- M000602359
- History note
- 2016 (1989)
- Public note
- 2016; SALMETEROL XINAFOATE was indexed under ALBUTEROL 1989-2015
Allowable subheadings
- AD
- administration & dosage 3
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history 1
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 10
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.033.100.291.057.125
Albuterol, Ipratropium Drug Combination
D02.033.100.291.057.500
Levalbuterol
D02.092.063.291.057.125
Albuterol, Ipratropium Drug Combination
D02.092.063.291.057.500
Levalbuterol
D02.092.471.683.061.125
Albuterol, Ipratropium Drug Combination
D02.092.471.683.061.500
Levalbuterol